Embryonal tumor with multilayered rosettes (EMBRYONAL CARCINOMA) is a rare malignant neoplasm characterized by the formation of multilayered neural and mesodermal tissues. It arises early in development from pluripotent cells undergoing embryogenesis. This tumor usually occurs in children and young adults and belongs to a group of tumors known as teratomas, which can contain different types of cells. Diagnosis and treatment of this tumor require a comprehensive approach taking into account the age specificity and genetic predisposition of the patient.
History of the disease and interesting historical facts
The history of embryonal tumor research goes back to the early 20th century, when scientists first began describing so-called “primary tumors” in children. In the 1940s and 1950s, the foundations for classifying different types of tumors, including embryonal carcinoma, were developed. Interestingly, the original pathological studies of these tumors were based on samples obtained from patients in the post-war period. At this time, the first steps were taken toward understanding the biology of embryonal tumors. Our current understanding of embryonal tumors has been significantly changed by genetic studies, which have revealed the molecular mechanisms underlying their development.
Epidemiology
Embryonal tumor with multilayered rosettes is quite rare, making it difficult to collect statistics. Its prevalence is estimated to be approximately 1.3-4.5 cases per 100,000 live births. Epidemiological studies show that the disease is more common in boys than in girls and is most often diagnosed between the ages of 2 and 4 years. Notably, there has been a recent trend towards an increase in the incidence, which may be due to improved diagnostics and increased awareness among the medical community.
Genetic predisposition to this disease
The genetic basis of embryonal tumor with multilayered rosettes is characterized by various mutations in key genes. Of primary interest is the TP53 gene, responsible for cell cycle control and apoptosis, mutations of which are registered in most patients with this diagnosis. Also noted is the involvement of genes regulating cell differentiation processes, such as NANOG and OCT4, which play a critical role in maintaining the pluripotency of stem cells. The presence of these gene changes may serve as a predisposing factor for tumor development and has been identified in a number of clinical studies.
Risk factors for the development of this disease
Among the risk factors for the development of embryonal tumor with multilayered rosettes are the following:
- Physical factors: A history of radiation exposure may increase the likelihood of tumor development.
- Chemical factors: Long-term exposure to certain carcinogens such as cadmium or arsenic.
- Environmental factors: high levels of air pollution and the presence of toxic substances in the ecosystem.
- Personal and family history: Having a history of cancer in close relatives may increase your risk.
Diagnosis of this disease
The main symptoms of embryonal tumor with multilayered rosettes may vary depending on the location and stage of the disease. Classic manifestations include:
- General weakness and fatigue;
- Frequent painful sensations in the abdominal area;
- Enlarged lymph nodes and weight loss;
- Anemia and other systemic symptoms.
Laboratory tests include tests for tumor markers such as alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG), as well as a complete blood count to check for anemia. Radiological tests such as ultrasound, CT, and MRI are important tools for visualizing the tumor and its spread.
Differential diagnosis includes exclusion of other types of tumors such as teratoma and neuroblastoma.
Treatment
Treatment of embryonal tumor with multilayered rosettes requires a comprehensive approach, including:
- General treatment: Depending on the stage of the disease, observation or active treatment may be used.
- Pharmacological treatment: Chemotherapy courses using drugs such as paclitaxel and cisplatin are widely used.
- Surgical treatment: Complete removal of the tumor is the preferred method, especially in early stages.
- Other treatments: In some cases, radiation therapy may be considered.
List of medications used to treat this disease
- Cisplatin
- etoposide
- Doxorubicin
- Paclitaxel
- Fluorouracil
Disease monitoring
Monitoring of patients with embryonal tumors includes regular follow-up examinations using laboratory tests for tumor markers and imaging studies. The prognosis depends on the stage of the disease at the time of diagnosis and the individual characteristics of the patient, but early diagnosis and adequate treatment significantly increase the chances of recovery. Possible complications may include tumor recurrence, metastasis, and toxic effects of chemotherapy on organs.
Age-related features of the disease
Embryonal tumor with multilayered rosettes is usually diagnosed in children and adolescents, but can also occur in young adults. The disease in children usually has a more favorable prognosis compared with similar cases in adults, which may be due to differences in the biology of the tumor and the way the body responds to treatment.
Questions and Answers
- What is embryonal tumor with multilayered rosettes? It is a rare malignant tumor that develops from stem cells in the early stages of embryogenesis.
- What age is most susceptible to this disease? Most often the disease is diagnosed in children aged 2 to 4 years.
- What are the main treatment methods? Treatment includes surgery and chemotherapy, with the possibility of using radiotherapy.
- How often does the disease recur? Relapses may occur, especially in cases of late diagnosis and inadequate treatment, so constant monitoring is necessary.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov emphasizes the importance of early diagnosis of embryonic tumor with multilayered rosettes: "Do not forget about symptoms such as frequent fatigue and pain. If you have any suspicions, consult a specialist and do not postpone the examination. Modern diagnostic methods allow us to detect the disease at an early stage, which significantly increases the chances of successful treatment."
